GSA Capital Partners LLP Lowers Stake in Vitamin Shoppe Inc (VSI)

GSA Capital Partners LLP trimmed its position in shares of Vitamin Shoppe Inc (NYSE:VSI) by 42.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,356 shares of the specialty retailer’s stock after selling 10,599 shares during the quarter. GSA Capital Partners LLP owned 0.06% of Vitamin Shoppe worth $100,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of VSI. Schwab Charles Investment Management Inc. raised its position in shares of Vitamin Shoppe by 29.4% during the first quarter. Schwab Charles Investment Management Inc. now owns 863,237 shares of the specialty retailer’s stock worth $3,756,000 after purchasing an additional 196,125 shares during the period. California Public Employees Retirement System raised its position in shares of Vitamin Shoppe by 5.0% during the first quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock worth $1,230,000 after purchasing an additional 13,338 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Vitamin Shoppe by 10.4% during the first quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock worth $7,288,000 after purchasing an additional 158,123 shares during the period. Millennium Management LLC acquired a new position in shares of Vitamin Shoppe during the first quarter worth approximately $1,628,000. Finally, Nisa Investment Advisors LLC purchased a new stake in Vitamin Shoppe in the 2nd quarter valued at $129,000. 89.55% of the stock is currently owned by institutional investors.

In related news, CEO Sharon M. Leite purchased 5,500 shares of the stock in a transaction that occurred on Friday, August 31st. The stock was acquired at an average cost of $12.64 per share, with a total value of $69,520.00. Following the transaction, the chief executive officer now owns 5,500 shares of the company’s stock, valued at approximately $69,520. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Guillermo Marmol purchased 8,900 shares of the stock in a transaction that occurred on Friday, August 10th. The stock was bought at an average cost of $11.21 per share, with a total value of $99,769.00. Following the completion of the transaction, the director now directly owns 49,479 shares in the company, valued at approximately $554,659.59. The disclosure for this purchase can be found here. Corporate insiders own 18.50% of the company’s stock.

VSI has been the subject of a number of analyst reports. Zacks Investment Research lowered Vitamin Shoppe from a “strong-buy” rating to a “hold” rating in a research report on Saturday, September 22nd. ValuEngine lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Friday, June 1st. Morgan Stanley initiated coverage on Vitamin Shoppe in a research report on Monday, September 17th. They issued an “equal weight” rating and a $14.00 price target for the company. Finally, Barclays lowered Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a research report on Friday, September 7th.

NYSE VSI opened at $10.35 on Thursday. The firm has a market capitalization of $266.99 million, a P/E ratio of 26.54 and a beta of 0.74. Vitamin Shoppe Inc has a 12 month low of $2.95 and a 12 month high of $13.95. The company has a quick ratio of 0.32, a current ratio of 1.96 and a debt-to-equity ratio of 0.32.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings results on Wednesday, August 8th. The specialty retailer reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.27. The business had revenue of $293.10 million during the quarter, compared to analyst estimates of $279.87 million. Vitamin Shoppe had a positive return on equity of 2.42% and a negative net margin of 8.76%.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Further Reading: Asset Allocation, Balancing Your Investments

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply